$ELVN news

The latest ELVN stock news: headlines, filings, AI summaries and sentiment for $ELVN, updated around the clock.

• Enliven Therapeutics, Inc. - 10-Q Filing SEC EDGAR · November 5, 2026, 21:15 UTC
• Enliven Therapeutics, Inc. - 8-K Filing SEC EDGAR · November 5, 2026, 21:10 UTC
• Enliven Therapeutics, Inc. - 8-K Filing SEC EDGAR · October 14, 2026, 20:40 UTC
• Enliven and FDA Agree on Phase 3 Trial Design for Relcobatinib in Chronic Myeloid Leukemia Seeking Alpha · October 7, 2026, 03:12 UTC
• Enliven Therapeutics Director Sells $345,000 Worth of Shares Amid Stock Surge Motley Fool · June 27, 2026, 19:36 UTC
• Enliven Insider Sells $345K Worth of Shares Amid Stock's 62% Yearly Gain Yahoo Finance · June 27, 2026, 19:56 UTC
• OrbiMed Sells $39 Million Worth of Enliven Therapeutics Shares Amid Significant Stock Rally Yahoo Finance · June 27, 2026, 16:23 UTC
• OrbiMed Sells $39 Million Worth of Enliven Therapeutics Shares Amid Stock Rally Motley Fool · June 27, 2026, 16:03 UTC
• Orbimed Advisors Sells Shares of Enliven Theapeutics Yahoo Finance · June 24, 2026, 19:32 UTC
• Chief Medical Officer Sells Shares in Enliven Therapeutics Motley Fool · June 1, 2026, 21:25 UTC
• Enliven Therapeutics, Inc. - 10-Q Filing SEC EDGAR · May 7, 2026, 20:18 UTC
• Enliven Therapeutics, Inc. - 8-K Filing SEC EDGAR · May 7, 2026, 20:13 UTC